March 4, 2008 Press Release


 Exhibit 10.1 
 Press 
 Release 
 Source: 
 Senetek PLC 
 Senetek PLC in Dispute with Marketer of Pyratine-6TM 
 Investor Update Conference Call Set for March 7 
 NAPA, Calif., March 4, 2008/ PRNewswire-First Call/
— Senetek PLC (OTCBB: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging , today announced it has entered into a contractual dispute resolution process with Triax Aesthetics
LLC, the privately-held specialty pharmaceuticals marketer which Senetek licensed in August 2007 to sell a line of skincare products featuring Senetek’s new Pyratine-6TM active ingredient to dermatologists and other physicians who prescribe
or dispense products and to chain drug stores for sale at the pharmacist’s counter. 
 Senetek also announced that it will conduct a teleconference for
investors on Friday, March 7, 2008 at 9:00 a.m. Pacific time, 12:00 p.m. Eastern time, at which Senetek management will give an update on the business including the appointment of two veteran sales and marketing executives and a Vice President
of Communications. The domestic dial-in number will be 877-593-8638 and the international dial-in number will be 706-634-9240, conference ID 37979186. Replay of the conference call will be available until March 14, 2008, domestic replay dial-in
800-642-1687, international replay dial-in 706-645-9291, replay conference ID 37979186. 
 *
    *     *     * 
 About Senetek PLC 
 Senetek PLC (OTCBB: SNKTY) is a Life Sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The Company’s
extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical
companies in the final development and marketing of its proprietary products, most recently resulting in the development of the best-selling anti-aging product sold in the North American physician market. For more information, visit the
company’s website at http://www.senetekplc.com. 
 This news release contains statements that may be considered ‘forward-looking
statements’ within the meaning of the Private Securities Litigation Reform Act. Forward-looking statements by their nature involve substantial uncertainty, and actual results may differ materially from those that might be suggested by such
statements. Important factors identified by the Company that it believes could result in such material differences are described in the Company’s Annual Report on Form 10-K for the year 2006. However, the Company necessarily can give no 








 
assurance that it has identified or will identify all of the factors that may result in any particular forward-looking statement materially differing from
actual results, and the Company assumes no obligation to correct or update any forward-looking statements which may prove to be inaccurate, whether as a result of new information, future events or otherwise. 
 Company contact: 
 Marjorie Hays 
 Vice President, Communications 
 Senetek, PLC 
 1-707-226-3900 ext. 102